We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 723

FDA Warns Companies Illegally Marketing Dietary Supplements as Sunscreen
  • Keller and Heckman LLP
  • USA
  • May 23 2018

On May 22, 2018, FDA sent warning letters to companies illegally marketing dietary supplements that make unproven drug claims about sun protection


FDA Targets Highly Concentrated Caffeine in Dietary Supplements
  • Keller and Heckman LLP
  • USA
  • April 17 2018

As previously reported on this blog in 2015, FDA warned that it intended to “aggressively monitor the marketplace for pure powdered caffeine products


Consent Decree of Permanent Injunction Against Wholesale Manufacturer of Dietary Supplements
  • Keller and Heckman LLP
  • USA
  • April 2 2018

In a March 29, 2018 press release, the Food and Drug Administration (FDA) announced a consent decree entered by the US District Court for the Eastern


Companies Marketing CBD Products Be Warned: FDA Is Watching
  • Arent Fox LLP
  • USA
  • November 20 2017

The US Food and Drug Administration recently issued warning letters to four companies - Stanley Brothers Social Enterprises LLC, Greenroads Health


Food and Beverage News and Trends
  • DLA Piper
  • USA
  • November 7 2017

FDA proposes revoking heart-health claim for soy protein. Citing "inconsistent findings" in research, the FDA announced October 30 that it is


FDA Issues Warning About Dietary Supplements Containing Active Drug Ingredients
  • Stark & Stark
  • USA
  • October 11 2017

The FDA has issued a safety alert to consumers involving several dietary supplements including Rhino 7, Papa Zen, Fifty Shades, and Grande X. The


Life sciences: product regulation and liability in the USA
  • Perkins Coie LLP
  • USA, Global
  • October 11 2017

A structured guide to product regulation and liability in the USA


Cannabis Prop 65 Liability: Lessons Learned from the Dietary Supplement Industry
  • Wilson Elser
  • USA
  • October 3 2017

The cannabis industry appears to be next on the liability “hit list” under California’s notorious Proposition 65 statute. In June 2017, more than 700


Food and Drug Law Alert
  • Venable LLP
  • USA
  • September 13 2017

On September 5, 2017, the Food and Drug Administration (FDA) announced that it will hold a public meeting to discuss the development of an


Aligning a Product's Marketing, Regulatory and IP Plans
  • Pepper Hamilton LLP
  • USA
  • September 8 2017

Patent protection can be critical for health care products, including medical devices, prescription drugs, dietary supplements and software as a